# Randomized, Multicenter, Double-blind, Vancomycin-controlled Study to Evaluate the Efficacy of Ethanol Lock Solution for the Curative Treatment of Implantable Venous Access Port Infection Due to Coagulase-negative Staphylococci

> **NCT02411331** · NA · UNKNOWN · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 180 (estimated)

## Conditions studied

- Lock Solution
- Catheter Related Blood Stream Infections
- Central Venous Catheter Infection
- Intravenous Drug Delivery Systems
- Coagulase-negative Staphylococci Infection

## Interventions

- **DRUG:** Ethanol 40% + Enoxaparine 400UI/ml
- **DRUG:** Vancomycine 5 mg/ml + Héparine 2500UI/ml

## Key facts

- **NCT ID:** NCT02411331
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2016-07-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02411331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02411331, "Randomized, Multicenter, Double-blind, Vancomycin-controlled Study to Evaluate the Efficacy of Ethanol Lock Solution for the Curative Treatment of Implantable Venous Access Port Infection Due to Coagulase-negative Staphylococci". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02411331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*